Dyserythropoietic Anemia and ThrombocytopeniaSymptoms, Doctors, Treatments, Advances & More
Dyserythropoietic Anemia and Thrombocytopenia Overview
Learn About Dyserythropoietic Anemia and Thrombocytopenia
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Achille Iolascon practices practicing medicine in Naples, Italy. Mr. Iolascon is rated as an Elite expert by MediFind in the treatment of Dyserythropoietic Anemia and Thrombocytopenia. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Dyserythropoietic Anemia and Thrombocytopenia, Anemia, Congenital Hemolytic Anemia, Hemolytic Anemia, and Splenectomy.
Roberta Russo practices practicing medicine in Naples, Italy. Ms. Russo is rated as an Elite expert by MediFind in the treatment of Dyserythropoietic Anemia and Thrombocytopenia. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Dyserythropoietic Anemia and Thrombocytopenia, Anemia, Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.
Cristian Tornador practices practicing medicine in Esplugues De Llobregat, Spain. Mr. Tornador is rated as an Elite expert by MediFind in the treatment of Dyserythropoietic Anemia and Thrombocytopenia. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Dyserythropoietic Anemia and Thrombocytopenia, Jaundice, Hyperferritinemia-Cataract Syndrome, and Anemia.
Background: Congenital Dyserythropoietic Anemia (CDA) is a group of rare hereditary blood disorders characterized by ineffective erythropoiesis, leading to chronic anemia and organ damage. Current treatment options are very limited, mainly relying on regular blood transfusions, which can cause severe complications over time. Our laboratory research and animal models suggest that Zoledronic acid, a medication ...
Summary: The investigators have created and maintain a comprehensive registry for patients with the diagnosis of Congenital Dyserythropoietic Anemia (CDA) in North America. The goal of this registry is to collect long-term confidential data on patients with CDA in the US, Canada, and Mexico and maintain a bio-repository of de-identified patient blood and bone marrow specimens as a tool for the investigatio...